Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the …

Jan 11, 2026 · Tempus is in the process of completing its customary year-end close and review procedures for the quarter and year ended December 31, 2025, and there can be no assurance that …

6 days ago · Tempus plans to report its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. About Tempus Tempus is a technology company …

6 days ago · Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4.

Tempus AI ’s (TEM) preliminary results show its total contract value (TCV) surpassed $1.1 billion, marking the highest level in its history. The update reflects how quickly the AI‑driven healthcare …

3 days ago · JPM26: Tempus AI and the push toward precision medicine Founded in 2015, Tempus built a platform designed to turn real-world clinical information into structured, centralised, and actionable …

2 days ago · Complete Tempus AI Inc. stock information by Barron's. View real-time TEM stock price and news, along with industry-best analysis.

TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians …

Find the latest Tempus AI, Inc. (TEM) stock quote, history, news and other vital information to help you with your stock trading and investing.